Fighting bacteria with a new genre of antibodies

April 24, 2013
Fighting bacteria with a new genre of antibodies
To cope with bacteria that shrug off existing antibiotics and sterilization methods, scientists have developed a new family of selective anti-microbial agents that do not rely on traditional antibiotics. Credit: iStockphoto/Thinkstock

In an advance toward coping with bacteria that shrug off existing antibiotics and sterilization methods, scientists are reporting development of a new family of selective antimicrobial agents that do not rely on traditional antibiotics. Their report on these synthetic colloid particles, which can be custom-designed to recognize the shape of specific kinds of bacteria and inactivate them, appears in the Journal of the American Chemical Society.

Vesselin Paunov and colleagues point out that many bacteria have developed resistance to existing antibiotics. They sought a new approach—one that bacteria would be unable to elude by mutating into drug-resistant forms. Their inspiration was the antibodies that the immune system produces when microbes invade the body. Those antibodies patrol the body for microbes and bind to their surfaces, triggering a chain of events in which the body's and destroys the microbes.

Paunov's team describes development and successful tests of synthetic colloid particles, called "colloid antibodies." Colloids are materials in which of one material are dispersed in another material. Milk is a colloid in which globules of fat are spread throughout water and other materials. The colloid antibody particles are shells packed with a killing agent. They are designed to recognize and bind to specific bacteria.

Laboratory experiments showed that the colloid antibodies attached to and inactivated only their intended targets without harming other cells. "We anticipate that similar shape selective colloid antibodies can potentially become a powerful weapon in the fight against antibiotic-resistant bacteria," say the researchers. "They can also find applications as non-toxic , preventing growth of in various formulations."

The article is titled "Photothermal Colloid Antibodies for Shape-Selective Recognition and Killing of Microorganisms."

Explore further: Antibodies trick bacteria into killing each other

More information: Photothermal Colloid Antibodies for Shape-Selective Recognition and Killing of Microorganisms, J. Am. Chem. Soc., 2013, 135 (14), pp 5282–5285 DOI: 10.1021/ja400781f

Related Stories

Antibodies trick bacteria into killing each other

November 14, 2011

The dominant theory about antibodies is that they directly target and kill disease-causing organisms. In a surprising twist, researchers from the Albert Einstein College of Medicine have discovered that certain antibodies ...

Researchers design Alzheimer's antibodies

December 9, 2011

Researchers at Rensselaer Polytechnic Institute have developed a new method to design antibodies aimed at combating disease. The surprisingly simple process was used to make antibodies that neutralize the harmful protein ...

(Antibody) orientation matters

December 10, 2012

The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacteria ...

Recommended for you

New method developed for producing some metals

August 25, 2016

The MIT researchers were trying to develop a new battery, but it didn't work out that way. Instead, thanks to an unexpected finding in their lab tests, what they discovered was a whole new way of producing the metal antimony—and ...

Electron microscopy reveals how vitamin A enters the cell

August 25, 2016

Using a new, lightning-fast camera paired with an electron microscope, Columbia University Medical Center (CUMC) scientists have captured images of one of the smallest proteins in our cells to be "seen" with a microscope.

Hitching a ride: Misfiring drugs hit the wrong targets

August 25, 2016

It probably isn't surprising to read that pharmaceutical drugs don't always do what they're supposed to. Adverse side effects are a well-known phenomenon and something many of us will have experienced when taking medicines.

Using light to control genome editing

August 25, 2016

The genome-editing system known as CRISPR allows scientists to delete or replace any target gene in a living cell. MIT researchers have now added an extra layer of control over when and where this gene editing occurs, by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.